Anne Bording Jensen
Senior Vice President, Clinical Operations, Novo Nordisk A/S
Graduated as DVM (Diploma Veterinary Medicine) from the Royal Veterinary and Agricultural University in Copenhagen and later supplemented with a PhD in immunology, epidemiology and biostatistics from the same university.
Subsequent to that, Anne has 25 years of experience working in Novo Nordisk. She has held a series of senior management positions over the years including regulatory, non-clinical development and project management. During the years, she has been key in the global regulatory submission and approval processes for multiple Novo Nordisk products across therapy areas.
Anne has been head of Novo Nordisk Clinical Operations since 2009. The responsibilities range from the global clinical development processes across all development phases and projects, to IT, Clinical Sourcing, Business Ethics in R&D and often also in the global organisation executing the clinical trials. Global projects to continuously improve processes and to secure compliance – could be Risk Based Monitoring, CDISC or RWD/RWE – are also under the auspices of Anne.